P5 Anchor-Based Thresholds for Meaningful Within-Patient Change in the Phase 3 Trial to Evaluate Tislelizumab for the Treatment of 2/3L NSCLC
Value in Health(2022)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined